These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 12915650

  • 1. Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
    Grinspoon SK, Friedman AJ, Miller KK, Lippman J, Olson WH, Warren MP.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3651-6. PubMed ID: 12915650
    [Abstract] [Full Text] [Related]

  • 2. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study.
    Warren MP, Miller KK, Olson WH, Grinspoon SK, Friedman AJ.
    Contraception; 2005 Sep; 72(3):206-11. PubMed ID: 16102557
    [Abstract] [Full Text] [Related]

  • 3. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
    Vescovi JD, VanHeest JL, De Souza MJ.
    Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ.
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [Abstract] [Full Text] [Related]

  • 5. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [Abstract] [Full Text] [Related]

  • 6. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
    Thorneycroft lH, Gollnick H, Schellschmidt I.
    Cutis; 2004 Aug; 74(2):123-30. PubMed ID: 15379365
    [Abstract] [Full Text] [Related]

  • 7. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
    Poindexter AN, Burkman R, Fisher AC, LaGuardia KD.
    Int J Fertil Womens Med; 2003 Aug; 48(4):163-72. PubMed ID: 13677549
    [Abstract] [Full Text] [Related]

  • 8. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study.
    Strokosch GR, Friedman AJ, Wu SC, Kamin M.
    J Adolesc Health; 2006 Dec; 39(6):819-27. PubMed ID: 17116511
    [Abstract] [Full Text] [Related]

  • 9. Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.
    LaGuardia KD, Shangold G, Fisher A, Friedman A, Kafrissen M.
    Contraception; 2003 Jun; 67(6):431-7. PubMed ID: 12814811
    [Abstract] [Full Text] [Related]

  • 10. The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
    Zhang J, Chung E, Yones C, Persson A, Mahnke L, Eley T, Xu X, Bertz R.
    Antivir Ther; 2011 Jun; 16(2):157-64. PubMed ID: 21447864
    [Abstract] [Full Text] [Related]

  • 11. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
    Creinin MD, Lippman JS, Eder SE, Godwin AJ, Olson W.
    Contraception; 2002 Sep; 66(3):147-52. PubMed ID: 12384201
    [Abstract] [Full Text] [Related]

  • 12. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
    Hampton RM, Fisher AC, Pagano S, LaGuardia KD.
    Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189
    [Abstract] [Full Text] [Related]

  • 13. The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris.
    Olson WH, Lippman JS, Robisch DM.
    Int J Fertil Womens Med; 1998 Aug; 43(6):286-90. PubMed ID: 9920537
    [Abstract] [Full Text] [Related]

  • 14. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J.
    Int J Fertil; 1991 Aug; 36 Suppl 1():25-31. PubMed ID: 1678378
    [Abstract] [Full Text] [Related]

  • 15. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S, Caubel P, Garnero P, Felsenberg D.
    Maturitas; 2004 Jul 15; 48(3):197-207. PubMed ID: 15207885
    [Abstract] [Full Text] [Related]

  • 16. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Jul 15; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 17. Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
    Schmitt-Hoffmann AH, Roos B, Sauer J, Schleimer M, Schoetzau A, Leese PT, Weidekamm E, Maares J.
    Clin Exp Dermatol; 2011 Apr 15; 36 Suppl 2():4-11. PubMed ID: 21443598
    [Abstract] [Full Text] [Related]

  • 18. Long-term profile of a new progestin.
    Lippman J.
    Int J Fertil; 1992 Apr 15; 37 Suppl 4():218-22. PubMed ID: 1362189
    [Abstract] [Full Text] [Related]

  • 19. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea.
    Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S, Herzog D, Klibanski A.
    J Clin Endocrinol Metab; 1999 Jun 15; 84(6):2049-55. PubMed ID: 10372709
    [Abstract] [Full Text] [Related]

  • 20. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Jun 15; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.